GCNT1 and neoplasm: Using the CHO-131 monoclonal antibody (mAb) which specifically detects C2-O-sLeX[28], we directly examined the ability of tumor cells transduced with C2GnT1 shRNA and expressing low levels C2-O-sLeX to bind to selectins.